Clinical Trials, Drug Manufacturers

Development of a Solid Dose Injection Recombinant Anthrax Vaccine

By Glide Technologies

Glide Technologies is a UK development company focused on solid dose formulations of therapeutics and vaccines, and non-invasive diagnostics.

Glide's SDI (solid dose injection) system comprises a re-useable spring powered actuator and a disposable single use cassette, which houses the vaccine formulated in a small solid formulation.

Pressing the loaded Glide SDI against the injection site 'charges' a spring in the actuator, which at a preset compression force pushes the vaccine into the subcutaneous layer.

The formulation dissolves, releasing the API or vaccine antigens into the surrounding tissue.

Download to find out more.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.